Open access
Open access
Powered by Google Translator Translator

Arrhythmias/Electrophysiology

Evaluation of an ambulatory ECG analysis platform using deep neural networks in routine clinical practice.

20 Sep, 2022 | 13:14h | UTC

Evaluation of an Ambulatory ECG Analysis Platform Using Deep Neural Networks in Routine Clinical Practice – Journal of the American Heart Association

 

Commentary on Twitter

 


AHA Scientific Statement | Management of patients at risk for and with left ventricular thrombus.

16 Sep, 2022 | 13:00h | UTC

Management of Patients at Risk for and With Left Ventricular Thrombus: A Scientific Statement From the American Heart Association – Circulation

 


Early versus delayed non–vitamin k antagonist oral anticoagulant therapy after acute ischemic stroke in atrial fibrillation: a registry-based randomized controlled noninferiority study.

8 Sep, 2022 | 14:46h | UTC

Early Versus Delayed Non–Vitamin K Antagonist Oral Anticoagulant Therapy After Acute Ischemic Stroke in Atrial Fibrillation (TIMING): A Registry-Based Randomized Controlled Noninferiority Study – Circulation (free for a limited period)

Related: Defining key design elements of registry-based randomised controlled trials: a scoping review – Trials

 

Commentary on Twitter

 


Predictive role of atrial fibrillation in cognitive decline: a systematic review and meta-analysis of 2.8 million individuals.

7 Sep, 2022 | 12:30h | UTC

Predictive role of atrial fibrillation in cognitive decline: a systematic review and meta-analysis of 2.8 million individuals – EP Europace

 

Commentary on Twitter (thread – click for more)

Under a https://creativecommons.org/licenses/by/4.0/ license

 


Cohort Study | Habitual alcohol intake and risk of atrial fibrillation in young adults.

5 Sep, 2022 | 14:33h | UTC

Habitual Alcohol Intake and Risk of Atrial Fibrillation in Young Adults in Korea – JAMA Network Open

Invited Commentary: Self-reported Alcohol Consumption and Risk of Atrial Fibrillation – JAMA Network Open

 


#ESCCongress – RCT | In patients with rheumatic heart disease–associated atrial fibrillation, treatment with a Vitamin K antagonist led to a lower rate of cardiovascular events or death compared to Rivaroxaban.

29 Aug, 2022 | 12:33h | UTC

Rivaroxaban in Rheumatic Heart Disease–Associated Atrial Fibrillation – New England Journal of Medicine (link to abstract – $ for full-text)

News Release: Trial backs standard of care for rheumatic heart disease and atrial fibrillation – European Society of Cardiology

Commentary: INVICTUS: More Deaths, Stroke With Rivaroxaban in Rheumatic Heart Disease AF – TCTMD

 

Commentary on Twitter

 


#ESCCongress | 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.

29 Aug, 2022 | 12:21h | UTC

2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Developed by the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC) Endorsed by the Association for European Paediatric and Congenital Cardiology (AEPC) – European Heart Journal

News Release: People of all ages should learn cardiopulmonary resuscitation – European Society of Cardiology

 


#ESCCongress – Single-arm study | Efficacy and safety of an extravascular implantable cardioverter–defibrillator.

29 Aug, 2022 | 12:09h | UTC

Efficacy and Safety of an Extravascular Implantable Cardioverter–Defibrillator – New England Journal of Medicine (link to abstract – $ for full-text)

 

Commentary on Twitter

 


Secondary analysis of a RCT | Early rhythm control in patients with atrial fibrillation and high comorbidity burden.

24 Aug, 2022 | 14:11h | UTC

Early Rhythm Control in Patients With Atrial Fibrillation and High Comorbidity Burden – Circulation

 

Commentary on Twitter

 


Review | Left atrial appendage occlusion, a misnomer?

22 Aug, 2022 | 12:01h | UTC

Left Atrial Appendage Occlusion, A Misnomer? – Mayo Clinic Proceedings

 


Review | Why is my patient still in sinus tachycardia?

17 Aug, 2022 | 14:06h | UTC

Why Is My Patient Still In Sinus Tachycardia? – emDocs

 


Cohort Study | Association of body mass index with outcomes in patients with newly diagnosed atrial fibrillation.

15 Aug, 2022 | 11:38h | UTC

Association of body mass index with outcomes in patients with newly diagnosed atrial fibrillation: GARFIELD-AF – openheart

Commentary: ‘Obesity Paradox’ in Atrial Fibrillation Challenged as Mortality Climbs With BMI – Medscape (free registration required)

 

Commentary from the author on Twitter (thread – click for more)

 


EHRA expert consensus statement on arrhythmic mitral valve prolapse and mitral annular disjunction complex.

12 Aug, 2022 | 14:48h | UTC

EHRA expert consensus statement on arrhythmic mitral valve prolapse and mitral annular disjunction complex in collaboration with the ESC Council on valvular heart disease and the European Association of Cardiovascular Imaging endorsed cby the Heart Rhythm Society, by the Asia Pacific Heart Rhythm Society, and by the Latin American Heart Rhythm Society – EP Europace

 


Cohort Study | Age at menopause and risk of heart failure and atrial fibrillation.

5 Aug, 2022 | 14:38h | UTC

Age at menopause and risk of heart failure and atrial fibrillation: a nationwide cohort study – European Heart Journal (link to abstract – $ for full-text)

Editorial: Premature menopause and cardiovascular disease: can we blame estrogen? – European Heart Journal

News Release: Premature menopause is associated with increased risk of heart problems – European Society of Cardiology

 


Cohort Study | Incidence, associated risk factors, and outcomes of postoperative arrhythmia after upper gastrointestinal surgery.

26 Jul, 2022 | 11:52h | UTC

Incidence, Associated Risk Factors, and Outcomes of Postoperative Arrhythmia After Upper Gastrointestinal Surgery – JAMA Network Open

Commentary: Incidence and Outcomes of Postop Arrhythmia After Upper GI Surgery – American College of Cardiology

 

Commentary on Twitter

 


M-A | Utility of provocative testing in the diagnosis and genotyping of congenital long QT syndrome.

13 Jul, 2022 | 11:13h | UTC

Utility of Provocative Testing in the Diagnosis and Genotyping of Congenital Long QT Syndrome: A Systematic Review and Meta‐Analysis – Journal of the American Heart Association

 


Retrospective Cohort Study | New-onset atrial fibrillation in intensive care: epidemiology and outcomes.

13 Jul, 2022 | 11:11h | UTC

New-onset atrial fibrillation in intensive care: epidemiology and outcomes – European Heart Journal. Acute Cardiovascular Care

 

Commentary on Twitter

Under a https://creativecommons.org/licenses/by-nc/4.0/ License

 


RCT | First-line catheter ablation of monomorphic ventricular tachycardia in cardiomyopathy concurrent with defibrillator implantation.

11 Jul, 2022 | 12:21h | UTC

First-Line Catheter Ablation of Monomorphic Ventricular Tachycardia in Cardiomyopathy Concurrent With Defibrillator Implantation: The PAUSE-SCD Randomized Trial – Circulation

 

Commentary on Twitter

 


M-A | DOACs vs. VKAs in atrial fibrillation patients with bioprosthetic heart valve.

7 Jul, 2022 | 12:15h | UTC

An Updated Meta-Analysis of DOACs vs. VKAs in Atrial Fibrillation Patients With Bioprosthetic Heart Valve – Frontiers in Cardiovascular Medicine

 


Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator.

5 Jul, 2022 | 11:29h | UTC

Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator – European Heart Journal

Related Study: Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator – European Heart Journal

Editorial: Arrhythmogenic right ventricular cardiomyopathy: the never-ending quest for a risk calculator


Cohort Study | Novel risk prediction model to determine adverse heart failure outcomes in arrhythmogenic right ventricular cardiomyopathy.

4 Jul, 2022 | 11:53h | UTC

Novel Risk Prediction Model to Determine Adverse Heart Failure Outcomes in Arrhythmogenic Right Ventricular Cardiomyopathy – Journal of the American Heart Association

Editorial: Predicting Heart Failure in Arrhythmogenic Right Ventricular Cardiomyopathy


Retrospective Cohort Study: Atrial fibrillation after surgery is linked to an increased risk of hospitalization for heart failure.

29 Jun, 2022 | 10:52h | UTC

News Release: Atrial fibrillation after surgery is linked to an increased risk of hospitalization for heart failure – European Society of Cardiology

Original Study: Post-operative atrial fibrillation and risk of heart failure hospitalization – European Heart Journal

Editorial: Post-operative AF and heart failure hospitalizations: what remains hidden in patients undergoing surgery – European Heart Journal

 

Commentary on Twitter

 


Review: Arrhythmias and heart failure in pregnancy.

29 Jun, 2022 | 10:48h | UTC

Arrhythmias and Heart Failure in Pregnancy: A Dialogue on Multidisciplinary Collaboration – Journal of Cardiovascular Development and Disease

 


Indications and utility of cardiac genetic testing in athletes.

28 Jun, 2022 | 11:03h | UTC

Indications and utility of cardiac genetic testing in athletes – European Journal of Preventive Cardiology

 


M-A: Direct oral anticoagulants vs. warfarin in hemodialysis patients with atrial fibrillation.

28 Jun, 2022 | 10:48h | UTC

Direct Oral Anticoagulants vs. Warfarin in Hemodialysis Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis – Frontiers in Cardiovascular Medicine

 


Stay Updated in Your Specialty

No spam, just news.